Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer

International Journal of Cancer

Volumn 140, Issue 7, 2017, Pages 1485-1493

  Jayasekara, Harindra ^a,b   MacInnis, Robert J ^a,b   Williamson, Elizabeth J ^c,d   Hodge, Allison M ^a   Clendenning, Mark ^e   Rosty, Christophe ^e,f,g   Walters, Rhiannon ^h   Room, Robin ^b,i,j   Southey, Melissa C ^e   Jenkins, Mark A ^b   Milne, Roger L ^a,b   Hopper, John L ^a,b   Giles, Graham G ^a,b   Buchanan, Daniel D ^b,e   English, Dallas R ^a,b  

^a CANCER EPIDEMIOLOGY CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Farr Institute of Health Informatics Research   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f Envoi Specialist Pathologists   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

ⁱ LA TROBE UNIVERSITY   (Australia)

^j STOCKHOLM UNIVERSITY   (Sweden)

more..

Author keywords

alcohol intake; BRAF; colorectal cancer; KRAS

Indexed keywords

ALCOHOL; B RAF KINASE; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; PROTEIN P21;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BRAF GENE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; ONCOGENE K RAS; PROSPECTIVE STUDY; SIGNAL TRANSDUCTION; ADENOMA; ADVERSE EFFECTS; ALCOHOLISM; ANTHROPOMETRY; CARCINOMA; COLORECTAL TUMOR; COMPLICATION; DRINKING BEHAVIOR; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; ONCOGENE RAS; QUESTIONNAIRE; RISK FACTOR;

ADENOMA; ADULT; AGED; ALCOHOL DRINKING; ALCOHOLISM; ANTHROPOMETRY; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS P21(RAS); RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 85007301752     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30568     Document Type: Article

References (54)

1. Baan R, Straif K, Grosse Y, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol 2007;8:292–3.
2. Jayasekara H, MacInnis RJ, Room R, et al. Long-term alcohol consumption and breast, upper aero-digestive tract and colorectal cancer risk: a systematic review and meta-analysis. Alcohol Alcohol 2015;51:315–30.
3. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007;50:113–30.
4. Phipps AI, Limburg PJ, Baron JA, et al. Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterology 2015;148:77–87. e2.
5. Ogino S, Chan AT, Fuchs CS, et al. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011;60:397–411.
6. Pai RK, Jayachandran P, Koong AC, et al. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon. Am J Surg Pathol 2012;36:744–52.
7. Rosty C, Young JP, Walsh MD, et al. Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Mod Pathol 2013;26:825–34.
8. Poynter JN, Haile RW, Siegmund KD, et al. Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev 2009;18:2745–50.
9. Samowitz WS, Albertsen H, Sweeney C, et al. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 2006;98:1731–8.
10. Limsui D, Vierkant RA, Tillmans LS, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst 2010;102:1012–22.
11. Slattery ML, Anderson K, Curtin K, et al. Dietary intake and microsatellite instability in colon tumors. Int J Cancer 2001;93:601–7.
12. Diergaarde B, Braam H, Muijen GNPv, et al. Dietary factors and microsatellite instability in sporadic colon carcinomas. Cancer Epidemiol Biomarkers Prev 2003;12:1130–6.
13. Eaton AM, Sandler R, Carethers JM, et al. 5,10-methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2023–9.
14. Satia JA, Keku T, Galanko JA, et al. Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 2005;14:429–36.
15. Schernhammer ES, Giovannucci E, Baba Y, et al. B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP). Plos One 2011;6:e21102
16. Razzak AA, Oxentenko AS, Vierkant RA, et al. Alcohol intake and colorectal cancer risk by molecularly defined subtypes in a prospective study of older women. Cancer Prev Res 2011;4:2035–43.
17. Seitz HK, Simanowski UA. Alcohol and carcinogenesis. Annu Rev Nutr 1988;8:99–119.
18. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ 2002;156:69–70.
19. Ireland P, Jolley D, Giles G, et al. Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pac J Clin Nutr 1994;3:19–31.
20. McLennan B. Socio-economic indexes for areas 96 [electronic resource]. Canberra: Australian Bureau of Statistics, 1998.
21. Lewis J, Milligan G, Hunt A. Nuttab95: nutrient data table for use in Australia. Canberra: Australian Government Publishing Service, 1995.
22. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949–54.
23. Buchanan DD, Sweet K, Drini M, et al. Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. Plos One 2010;5:e11636–e.
24. Rosty C, Buchanan DD, Walsh MD, et al. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol 2012;36:876–82.
25. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: Choice of the time-scale. Am J Epidemiol 1997;145:72–80.
26. Lunn M, McNeil D. Applying cox regression to competing risks. Biometrics 1995;51:524–32.
27. Harrell FE, Jr., Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 1988;80:1198–202.
28. Cleves MA, Gould WW, Gutierrez RG. An introduction to survival analysis using Stata, rev. ed. College Station, Texas: Stata Press, 2004.
29. Kirkwood BR, Sterne JAC. Essential medical statistics, 2nd ed. Malden, MA: Blackwell Science, 2010.
30. Collett D. Modelling survival data in medical research, 2nd ed. Boca Raton, FL: Chapman & Hall/CRC, 2003.
31. English DR, Young JP, Simpson JA, et al. Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev 2008; 17:1774–80.
32. Marshall JR, Freudenheim JO. Alcohol. In: Schottenfeld D, Fraumeni, JF. Cancer Epidemiology and Prevention, 3rd ed. New York: Oxford University Press, 2006.
33. Seitz HK, Pöschl G, Simanowski UA. Alcohol and cancer. Recent Dev Alcohol 1998;14:67–95.
34. Lieber CS. Mechanisms of ethanol-drug-nutrition interactions. J Toxicol Clin Toxicol 1994;32:631–81.
35. Ferrari P, McKay JD, Jenab M, et al. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphisms, alcohol intake and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study. Eu J Clin Nutr 2012;66:1303–8.
36. Arasaradnam RP, Commane DM, Bradburn D, et al. A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics 2008;3:193–8.
37. Mathers JC, Strathdee G, Relton CL. Induction of epigenetic alterations by dietary and other environmental factors. Adv Genet 2010;71:3–39.
38. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005;129:837–45.
39. Nosho K, Irahara N, Shima K, et al. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. Plos One 2008;3:1–12.
40. Sanchez JA, Krumroy L, Plummer S, et al. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer. Br J Surg 2009;96:1196–204.
41. Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn 2008;10:13–27.
42. Ogino S, Kawasaki T, Kirkner GJ, et al. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Gut 2007;56:1564–71.
43. Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999;96:8681–6.
44. Jass JR. Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2005;2:398–405.
45. Toon CW, Walsh MD, Chou A, et al. BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome. Am J Surg Pathol 2013;37:1592–602.
46. Lièvre A, Bachet J-B, Le Corre D, et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 2006;66:3992–5.
47. O'Brien MJ. Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 2007;36:947–68. viii.
48. O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006;30:1491–501.
49. East JE, Saunders BP, Jass JR. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am 2008;37:25–46.
50. Goldstein NS. Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. Am J Clin Pathol 2006;125:146–53.
51. Kambara T, Simms LA, Whitehall V, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004;53:1137–44.
52. Burnett-Hartman AN, Passarelli MN, Adams SV, et al. Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol 2013;177:625–37.
53. Moskal A, Norat T, Ferrari P, et al. Alcohol intake and colorectal cancer risk: A dose-response meta-analysis of published cohort studies. Int J Cancer 2007;120:664–71.
54. Ferrari P, Jenab M, Norat T, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2007;121:2065–72.